Past, present, and future - MBSW Online

• Meyer, R.E. et al.(2010) Suicidality and risk of suicide--definition, drug safetyconcerns, and a necessary target for drug development: A brief report. J ClinPsychiatry 71, 1040-6.• Oquendo, M.A., Halberstam, B. & Mann, J.J.(2008) Columbia Suicide HistoryForm. In: Handbook of Psychiatric Measures, Vol. 2nd (eds. Rush, J., First, M.B.and Black, D.) 241-2 (American Psychiatric Publishing, Inc;, Washington, D.C.• Osman, A., Bagge, C.L., Gutierrez, P.M., Konick, L.C., Kopper, B.A. & Barrios,F.X. (2001) The Suicidal Behaviors Questionnaire-Revised (SBQ-R): Validationwith clinical and nonclinical samples. Assessment 8, 443-54.• PhRMA White Paper, December 2008, on the Assessment of Suicidality ,December 19, 2008. On file upon request.• Posner, K., Oquendo, M., Gould, M., Stanley, B. & Davies (2007), M. ColumbiaClassification Algorithm of Suicide Assessment (C-CASA): Classification ofsuicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. AmJ Psychiatry 164, 1035-43.• Posner, K., Melvin, G.A., Stanley, B., Oquendo, M.A. & Gould, M.(2007)Factors in the assessment of suicidality in youth. CNS Spectr 12, 156-62.• Stone, M. et al. (2009) Risk of suicidality in clinical trials of antidepressants inadults: analysis of proprietary data submitted to US Food and DrugAdministration. BMJ 339, b2880.Muncie, IN May 25, 2011 C. Gassmann-Mayer Johnson & Johnson40